Tsutsumi Y, Yamamoto T, Shimono J, Ohhigashi H, Teshima T.: Hepatitis B virus reactivation with rituximab-containing regimen. World J Hepatol. 5(11). 612-620. 2013
英文原著
Shima T, Miyamoto T, Kikushige Y, Mori Y, Kamezaki K, Takase K, Henzan N, Numata A, Ito A, Takenaka K, Iwasaki H, Kamimura T, Eto T, Nagafuji K, Teshima T, Kato K, Akashi K.: Quantification of hematogones at the time of engraftment is a useful prognostic indicator in allogeneic stem cell transplantation. Blood. 121(5). 840-848. 2013
Shima T, Forraz N, Sato N, Yamauchi T, Iwasaki H, Takenaka K, Akashi K, McGuckin C, Teshima T.: A novel filtration method for cord blood processing using a polyester fabric filter. Int J Lab Hematol. 35. 436-446. 2013
Uchida M, Ikesue H, Kato K, Ichinose K, Hiraiwa H, Sakurai A, Takenaka K, Iwasaki H, Miyamoto T, Teshima T, Egashira N, Akashi K, Oishi R.: Antiemetic effectiveness and safety of aprepitant in patients with hematologic malignancy receiving multiday chemotherapy. Am J Health Syst Pharm. 70(4). 343-349. 2013
Muta T, Miyamoto T, Fujisaki T, Ohno Y, Kamimura T, Kato K, Takenaka K, Iwasaki H, Eto T, Takamatsu Y, Teshima T, Akashi K.: Evaluation of the feasibility and efficacy of autologous stem cell transplantation in elderly patients with multiple myeloma. Intern Med. 52(1). 63-70. 2013
Watanabe H, Ikesue H, Tsujikawa T, Nagata K, Uchida M, Suetsugu K, Egashira N, Muta T, Kato K,Takenaka K, Ohga S, Matsushima T, Shiratsuchi M, Miyamoto T, Teshima T, Akashi K, Oishi R.: Decrease in venous irritation by adjusting the concentration of injected bendamustine. Biol Pharm Bull. 36(4). 574-578. 2013
Yamasaki S, Miyagi-Maeshima A, Kakugawa Y, Matsuno Y, Ohara-Waki F, Fuji S, Morita-Hoshi Y,Mori M, Kim S, Mori S, Fukuda T, Tanosaki R, Shimono T, Tobinai K, Saito D, Takaue Y, Teshima T, Heike Y.: Diagnosis and evaluation of intestinal graft-versus-host disease after allogeneic hematopoietic stem cell. Int J Hematol. 97(3). 421-426. 2013
Miyatake Y, Oliveira AL, Jarboui MA, Ota S, Tomaru U, Teshima T, Hall WW, Kasahara M.: Protective Roles of epithelial cells in the survival of adult T-cell leukemia/lymphoma cells. Am J Pathol. 182(5). 1832-1842. 2013
Uchida M, Ikesue H, Miyamoto T, Kato K, Suetsugu K, Ichinose K, Hiraiwa H, Sakurai A, Takenaka K, Muta T, Iwasaki H, Teshima T, Shiratsuchi M, Egashira N, Akashi K, Oishi R.: Effectiveness and safety of antiemetic aprepitant in Japanese patients receiving high-dose chemotherapy prior to autologous hematopoietic stem cell transplantation. Biol Pharm Bull. 36(5). 819-824. 2013
Uchida M, Kato K, Ikesue H, Ichinose K, Hiraiwa H, Sakurai A, Muta T, Takenaka K, Iwasaki H, Miyamoto T, Teshima T, EShiratsuchi M, Suetsugu K, Nagata K, Egashira N, Akashi K, Oishi R.: Efficacy and safety of aprepitant in allogeneic hematopoietic stem cell transplantation. Pharmacotherapy. 33(9). 893-901. 2013
Shimoji S, Kato K, Eriguchi Y, Takenaka K, Iwasaki H, Miyamoto T, Oda Y, Akashi K, Teshima T.: Evaluating the association between histological manifestations of cord colitis syndrome with GVHD. Bone Marrow Transplant. 48(9). 1249-1252. 2013
Eto T, Takase K, Miyamoto T, Ohno Y, Kamimura T, Nagafuji K, Takamatsu Y, Teshima T, Gondo H, Taniguchi S, Akashi K, Harada M.: Autologous peripheral blood stem cell transplantation with granulocyte colony-stimulating factor combined conditioning regimen as a postremission therapy for acute myelogenous leukemia in first complete remission. Int J Hematol. 98(2). 186-196. 2013
Muroi K, Miyamura K, Ohashi K, Murata M, Eto T, Kobayashi N, Taniguchi S, Imamura M, Ando K, Kato S, Mori T, Teshima T, Mori M, Ozawa K.: Unrelated allogeneic bone marrow-derived mesenchymal stem cells for steroid refractory acute graft-versus-host disease: a phase I/II study. Int J Hematol. 98(2). 206-213. 2013
Miyamoto T, Yoshimoto G, Kamimura T, Muta T, Takashima S, Ito Y, Shiratsuchi M, Choi I, Kato K, Takenaka K, Iwasaki H, Nagafuji K, Takamatsu Y, Teshima T, Akashi K.: Combination of high-dose melphalan and bortezomib as conditioning regimen for autologous peripheral blood stem cell transplantation in multiple myeloma. Int J Hematol. 98(3). 337-345. 2013
Aoyama K, Saha A, Tolar J, Riddle MJ, Veenstra RG, Taylor PA, Blomhoff R, Panoskaltsis-Mortari A, Klebanoff CA, Socie G, Munn DH, Murphy WJ, Serody JS, Fulton L, Teshima T, Chandraratna RA, Dmitrovsky E, Guo Y, Noelle RJ, Blazar BR.: Inhibiting retinoic acid signaling ameliorates graft-versus-host disease by modifying T-cell differentiation and intestinal migration. Blood. 122(12). 2125-2134. 2013
Eriguchi Y, Uryu H, Nakamura K, Shimoji S, Takashima S, Iwasaki H, Miyamoto T, Shimono N, Hashimoto D, Akashi K, Ayabe T, Teshima T.: Reciprocal expression of enteric antimicrobial proteins in intestinal graft-versus-host disease. Biol Blood Marrow Transplant. 19(10). 1525-1529. 2013
Koyama M, Hashimoto D, Nagafuji K, Eto T, Ohno Y, Aoyama K, Iwasaki H, Miyamoto T, Hill GR, Akashi K, Teshima T.: Expansion of donor-reactive host T cells in primary graft failure after allogeneic hematopoietic SCT following reduced-intensity conditioning. Bone Marrow Transplant. online. 2013
Ito Y, Miyamoto T, Kamimura T, Takase K, Henzan H, Sugio Y, Kato K, Ohno Y, Eto T, Teshima T, Akashi K.: Clinical outcomes of allogeneic stem cell transplantation for relapsed or refractory follicular lymphoma: a retrospective analysis by the Fukuoka Blood and Marrow Transplantation Group. Int J Hematol. 98(4). 463-471. 2013
Sugiyama H, Maeda Y, Nishimori H, Yamasuji Y, Matsuoka KI, Fujii N, Kondo E, Shinagawa K, Tanaka T, Takeuchi K, Teshima T, Tanimoto M.: Mammalian target of rapamycin inhibitors permit regulatory T cell reconstitution and inhibit experimental chronic graft-versus-host disease. Biol Blood Marrow Transplant. online. 2013
Shono Y, Shiratori S, Kosugi-Kanaya M, Ueha S, Sugita J, Shigematsu A, Kondo T, Hashimoto D, Fujimoto K, Endo T, Nishio M, Hashino S, Matsuno Y, Matsushima K, Tanaka J, Imamura M, Teshima T.: Bone marrow graft-versus-host disease: evaluation of its clinical impact on disrupted hematopoiesis after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. online. 2013
Nishijima T, Takano M, Ishisaka M, Komatsu H, Gatanaga H, Kikuchi Y, Endo T, Horiba M, Kaneda S, Uchiumi H, Koibuchi T, Naito T, Yoshida M, Tachikawa N, Ueda M, Yokomaku Y, Fujii T, Higasa S, Takada K, Yamamoto M, Matsushita S, Tateyama M, Tanabe Y, Mitsuya H, Oka S.: Abacavir/Lamivudine versus Tenofovir/Emtricitabine with Atazanavir/Ritonavir for treatment-naive Japanese patients with HIV-1 infection: A randomized multicenter trial. Internal Medicine. 52(7). 735-744. 2013
Nishijima T, Gatanaga H, Shimbo T, Komatsu H, Endo T, Horiba M, Koga M, Naito T, Itoda I, Tei M, Fujii T, Takada K, Yamamoto M, Miyakawa T, Tanabe Y, Mitsuya H, Oka S.: Switching tenofovir/emtricitabine plus lopinavir/r to raltegravir plus Darunavir/r in patients with suppressed viral load did not result in improvement of renal function but could sustain viral suppression: a randomized multicenter trial. PLoS One. 8(8). e73639. 2013
Schmeel LC, Schmeel FC, Kim Y, Endo T, Lu D, Schmidt-Wolf IG.: Targeting the wnt/beta-catenin pathway in multiple myeloma. Anticancer Res. 33(11). 4719-4726. 2013
Chow A, Huggins M, Ahmed J, Hashimoto D, Lucas D, Kunasaki Y, Pinho S, Leboeuf M, van Rooijen N, Tanaka M, Zhao ZJ, Merad M, Frenette PS.: CD169+ macrophages regulate erythropoiesis under homeostasis and in JAK2V617F-induced polycythemia vera. 19: 429-436, 2013. Nat Med. 19(4). 429-436. 2013
Hashimoto D, Chow A, Noizat C, Teo P, Beasley MB, Leboeuf M, Becker CD, See P, Price J, Lucas D, Greter M, Mortha A, Boyer SW, Forsberg EC, Tanaka M, van Rooijen N, Garcia-Sastre A, Stanley ER, Ginhoux F, Frenette PS, Merad M. Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes. Immunity. 38(4). 792-804. 2013
Kako S,Kanamori H, Kobayashi N, Shigematsu A, Nannya Y, Nakamae M, Shigeno K, Suzukawa K, Takeuchi M, Tsuzuki M, Usuki K, Hatanaka K, Ogaw K, Mitani K, Nawa Y, Hatta Y, Mizuno I, Kanda Y.: Outcome after first relapse in adult patients with Philadelphia chromosome-negative acute lymphoblastic leukaemia. Br J Haematol. 161(1). 95-103. 2013
Torimoto Y, Sato K, Ikuta K, Hayashi T,Hirayama Y, Inamura J, Kobayashi H, Kobayashi R, Koda K, Kurosawa M, Mori A, Ota S, Sakai H, Shigematsu A, Shindo M, Shinzaki H, Takahashi F, Takimoto R, Tanaka J, Yamamoto S, Kohgo Y, Fukuhara T.: A retrospective clinical analysis of Japanese patients with peripheral T-cell lymphoma not otherwise specified: Hokkaido Hematology Study Group. Int J Hematol. 98(2). 171-178. 2013
Kanamori H, Mizuta S, Kako S, Kato H, Nishiwaki S, Imai K, Shigematsu A, Nakamae H, Tanaka M, Ikegame K, Yujiri T, Fukuda T, Minagawa K, Eto T, Nagamura-Inoue T, Morishima Y, Suzuki R, Sakamaki H, Tanaka J.: Reduced-intensity allogeneic stem cell transplantation for patients aged 50 years or older with B-cell ALL in remission: a retrospective study by the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation. Bone Marrow Transplant. 48(12). 1513-1518. 2013
英文症例報告
Kato K, Miyamoto T, Numata A, Nakaike T, Oka H, Yurino A, Kuriyama T, Mori Y, Yamasaki S, Muta T, Takenaka K, Iwasaki H, Teshima T, Akashi K.: Diffuse panbronchiolitis after humanized anti-CCR4 monoclonal antibody therapy for relapsed adult T-cell leukemia/lymphoma. Int J Hematol. 97(3). 430-432. 2013
Tsutsumi Y, Shimono J, Miyashita N, Teshima T.: No effect of humanized CCR monoclonal antibody (Mogamulizumab) on treatment-resistant adult T-cell leukemia with meningeal infiltration. Leuk Lymphoma(letter). online. 2013
Nakaike T, Kato K, Oku S, Hayashi M, Kikushige Y, Kuroiwa M, Takenaka K, Iwasaki H, Miyamoto T, Teshima T, Ohshima K, Akashi K.: Reduced-intensity conditioning followed by cord blood transplantation in a patient with refractory folliculotropic mycosis fungoides. Int J Hematol. 98(4). 491-495. 2013
Shiratori S, Ito M, Yoneoka M, Hayasaka K, Hayase E, Iwasaki J, Sugita J, Shigematsu A, Fujimoto K, Kondo T, Shimizu C, Teshima T.: Successful Engraftment in HLA-Mismatched Bone Marrow Transplantation despite the Persistence of High-Level Donor-Specific Anti-HLA-DR Antibody. Transplantation(letter). 96(5). e34-44. 2013
Ohe M, Hashino S.: Successful treatment of recurrent follicular B-cell lymphoma with clarithromycin, prednisolone, and cyclophosphamide. Korean J Intern Med. 28(3). 2013 Mar. 377-379
Hashino S, Takahashi S, Morita R, Kanomori H, Onozawa M, Kawamura T, Kahata K, Kondo T, Tokimatsu I, Sugita T, Akizawa K, Asaka M.: Fungemia due to Trichosporon dermatis in a patient with refractory Burkitt’s leukemia. Blood Res. 48(2). 154-156. 2013
英文その他
Yamakawa T, Kurosawa M, Suzuki H.: Paravertebral extramedullary tumor of chronic myelogenous leukemia. International journal of hematology and oncology. 23(3). 202-203. 2013
